PFD report

Peter COLE · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 28 Feb 2020•Hertfordshire

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
1

Raised in this report

Recipients
1

Named on the report

Responses found
1

Of 1 recipient

Stated actions
8

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised1

  1. Lack of adequate monitoring of repeat medication
    Part of recurring concern: Unreliable review and monitoring of repeat prescriptions
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.6

  1. Action

    Publish dementia care pathway guidance recommending medication review and management, including monitoring and review resources.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 22 July 2020.
  2. Action

    Undertake a review of NHS over-prescribing and produce recommendations to reduce overprescribing and medicines wastage.

    Stated by NHS EnglandStated in progressThe respondent said that this action was in progress when they made their response on 22 July 2020.
  3. Action

    Operate the Medicines Safety Improvement Programme to reduce medication-related harm, focusing on high-risk drugs, situations and vulnerable patients.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 22 July 2020.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of adequate monitoring of repeat medication

Wider context from the report

“(1) That repeat medication is not being adequately monitored, leading to many (often older and/or mentally infirm) patients building-up dangerous quantities of prescribed medication. (2) That the inadequate supervision of prescribed (repeat) medication is so widespread that the consequent waste of resources has an adverse impact on the overall provision of healthcare. ”

Is this part of a recurring concern?

Yes — Unreliable review and monitoring of repeat prescriptions.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Publish dementia care pathway guidance recommending medication review and management, including monitoring and review resources.

Verbatim wording from the response

“In addition, to support improvement in dementia diagnosis and personalised care for people with dementia, NHS England published The Dementia Care Pathway: Full Implementation guidance. This resource sets out recommendations for reviewing and managing medication needs and provides examples of step-by-step best practice that includes monitoring and reviewing medication in the Appendices and Helpful Resources section of the guide.”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Undertake a review of NHS over-prescribing and produce recommendations to reduce overprescribing and medicines wastage.

Verbatim wording from the response

“• Undertaking a review of over-prescribing in the NHS which is due to report in Spring 2020. The review covers: the role of digital technologies; research; culture change and social prescribing; repeat prescribing; and transfer of care. The report will provide recommendations to reduce overprescribing which will help to reduce medicines wastage;”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Operate the Medicines Safety Improvement Programme to reduce medication-related harm, focusing on high-risk drugs, situations and vulnerable patients.

Verbatim wording from the response

“• The Medicines Safety Improvement Programme (MSIP) aims to reduce medication related harm in the NHS, focusing on high risk drugs, situations and vulnerable patients. The programme will contribute to the WHO Challenge target to reduce severe avoidable medication-related harm globally by 50% over five years.”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Support medicines optimisation through the Medicines Value Programme, including reducing use of clinically or cost-ineffective medicines.

Verbatim wording from the response

“• Supporting medicines optimisation through the Medicines Value Programme² to improve health outcomes from medicines through supporting people to take medicines as intended and, decreasing or stopping the use of medicines which are neither clinically - or cost-effective;”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Carry out structured medication reviews for patients at increased risk of medication-related harm.

Verbatim wording from the response

“has responsibility for. Several workstreams are currently in place to optimise prescribing and reduce medicines waste, these include:”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Refresh personalised dementia care and support planning guidance to emphasise medication reviews and appropriate medication access, continuation or cessation.

Verbatim wording from the response

“NHS England and Improvement also recently refreshed the Dementia: Good Personalised Care and Support Planning guide to help further enhance the provision of personalised post diagnostic support. The guide emphasises the need to include medication reviews to help to reduce poly pharmacy, minimise use of”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.2

  1. 1

    Connect patients appropriately to the New Medicines Service to support adherence to newly prescribed medicines.

    Stated by NHS EnglandStated plannedThe respondent said that this action was planned when they made their response on 22 July 2020.
  2. 2

    Encourage shared decision making through clinician-patient discussions addressing treatment options, evidence, risks, benefits and patient preferences.

    Stated by NHS EnglandStatus unclearThe respondent did not make the status of this action clear when they made their response on 22 July 2020.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Connect patients appropriately to the New Medicines Service to support adherence to newly prescribed medicines.

Verbatim wording from the response

“• Carrying out Structured Medication Reviews: As part of the five year GP contract Primary Care Networks (PCNS) are able to recruit additional staff to work in primary care teams, this includes including clinical pharmacists. Clinical pharmacists are increasingly working as part of general practice teams. They are highly qualified experts in medicines and can help people in a range of ways. This includes carrying out structured medication reviews for patients with ongoing health problems and improving patient safety, outcomes and value through a person-centred approach. They will support GP practices in prioritising patients who would benefit from a structured medication review. This will include patients in care homes; with complex and problematic polypharmacy; on medicines commonly associated with medication errors; and, with severe frailty, who are particularly isolated or housebound.”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Encourage shared decision making through clinician-patient discussions addressing treatment options, evidence, risks, benefits and patient preferences.

Verbatim wording from the response

“• Encouraging Shared Decision Making where a clinician supports a patient to reach a decision about their treatment by a conversation that brings together the clinician’s expertise: such as treatment options, evidence, risks and benefits; with what the patient knows best: their preferences, personal circumstances, goals, values and beliefs;”

Source location

2020-0123-Response-from-NHS-England.pdf
Page 2 · response
Published 22 July 2020

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
1/1

Data last updated 7 September 2026